None of the other measured mediators related to eosinophils and the T2 response (CCL26, IL-3, IL-4, IL-5, CD44, TSLP, or GM-CSF) displayed any significant differences between the different timepoints and between COVID-19 versus controls (Supplementary Figure S6). The gene discussed is IL4; the disease is COVID-19.